|- LGE donates KRW400 million to IVI|
- Financial ties aimed at vaccine development, joint education programs
- LGE pledges to expand contribution to improve global welfare
LG Electronics, a leading electronics maker based in Korea, has joined hands with the International Vaccine Institute (IVI) to improve global public welfare. The IVI is the world´s only international organization devoted exclusively to new vaccines for the poor, and is headquartered in Seoul, Korea.
On top of the IVI´s ‘New Vaccines to Save the World´s Children´ campaign for this year, LGE and the IVI agreed to work together to advance education programs and oversee international volunteer programs.
LGE and the IVI held a ceremony to sign an agreement stipulating their cooperation at the IVI headquarters on January 8. Kim Young-ki, Vice President for human resources at LGE, and Dr. John D. Clemens, Director-General of the IVI, attended the ceremony.
At this ceremony LGE also donated KRW400 million to the IVI to support the IVI´s efforts in saving the world´s children.
In the future the two sides hope to eliminate poverty and hunger and reduce child mortality through vaccine development. Additionally, they will operate joint education programs aimed at nurturing the next-generation of global scientists who will contribute to the development of society.
LGE Vice President Kim Young-ki said, "In order to live up to LG Electronics´ status as a global enterprise and to become a responsible corporate citizen, we will further expand our efforts to improve global social welfare."
Dr. Clemens said, "We are very privileged to have LG Electronics on board in our humanitarian efforts to save and improve lives of the world´s poorest children through life-saving vaccines. I am confident that LGE´s important contribution will serve as a catalyst for advancing humanity and science."About IVI
The International Vaccine Institute (IVI) is the world´s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world´s poorest people, especially children in developing countries. Based in Seoul, Korea, and established as an initiative of the United Nations Development Programme in 1997, the IVI operates under a treaty signed by 40 countries and the World Health Organization, and conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines against diarrheal infections, bacterial meningitis and pneumonia, as well as Japanese encephalitis and dengue fever. For more information, please visit www.ivi.int